Search results
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 6 days agoIn the first quarter, sales of weight-loss drug Zepbound skyrocketed and topped Wall Street's...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 5 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Why Caroline Stanbury Used Ozempic During "Midlife Crisis" Weight Gain
E! News via Yahoo News· 6 days agoReal Housewives of Dubai's Caroline Stanbury opened up about using Ozempic to lose weight, sharing,...
Compounding pharmacies are making their own versions of blockbuster weight loss drugs
KTEP 88.5 El Paso· 5 days agoAs more people turn to blockbuster drugs like Wegovy to lose weight, some are choosing to skip the name-brand drugs and go online for less expensive alternatives made by specialized ...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly (LLY), Novo Nordisk (NVO), Vertex Pharmaceuticals (VRTX), Intuitive Surgical (ISRG) and...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters· 1 day ago, opens new tab said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations and sending ...
CNBC Daily Open: Dow drops on weak manufacturing data, GameStop soars
CNBC· 1 day agoTraders work as a screen displays the trading information for GameStop and AMC Theatres on the floor...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters via Yahoo News· 2 days ago(Reuters) -Structure Therapeutics said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations ...
How Ozempic and GLP-1s Are Changing the Business of Travel
Skift· 4 days agoA growing number of consumers are turning to a class of drugs known as GLP-1’s, including Ozempic,...